Rate the Article: Observation on Role of Centchroman Versus Danazol in Treatment of Benign Breast Disorder, IJSR, Call for Papers, Online Journal
International Journal of Science and Research (IJSR)

International Journal of Science and Research (IJSR)
Call for Papers | Fully Refereed | Open Access | Double Blind Peer Reviewed

ISSN: 2319-7064

Downloads: 138 | Views: 414

Comparative Studies | Medical Surgical | India | Volume 6 Issue 8, August 2017 | Rating: 6.1 / 10


Observation on Role of Centchroman Versus Danazol in Treatment of Benign Breast Disorder

Dr Vijay Krishna Kumar, Dr Arshad Hasan


Abstract: Benign breast disorders includes spectrum of conditions which are related to the normal process of reproductive life and to involution. The common problem in benign breast disorders are breast pain, lump and nodularity. Many drugs have been tried for treatment of benign breast disorders like Danazol, Bromocriptine, Tamoxifen & LH-RH analogue but still a suitable drug is debatable. The aim of our study to analyse the effectiveness of drug Centchroman & its compare with Danazol in benign breast disorders in respect to symptoms relief, decrease in nodularity and lump size, recurrence, cost and side effects of drug. This prospective study was conducted on 64 patients of benign breast disorders attending surgical opd between January 2012 to august 2o13 in Patna medical college & hospital patna. The study shows that centchroman offers a safe, more effective and less expensive to Danazol for the treatment of benign breast disorders in long term.


Keywords: Benign breast disorder, Breast pain, Breast lump, Centchroman, Danazol


Edition: Volume 6 Issue 8, August 2017,


Pages: 683 - 685



Rate this Article


Select Rating (Lowest: 1, Highest: 10)

5

Your Comments (Only high quality comments will be accepted.)

Characters: 0

Your Full Name:


Your Valid Email Address:


Verification Code will appear in 2 Seconds ... Wait

Top